Literature DB >> 25398640

Autoimmune diagnostics: the technology, the strategy and the clinical governance.

Nicola Bizzaro1, Renato Tozzoli, Danilo Villalta.   

Abstract

In recent years, there has been a profound change in autoimmune diagnostics. From long, tiring and inaccurate manual methods, the art of diagnostics has turned to modern, rapid and automated technology. New antibody tests have been developed, and almost all autoimmune diseases now have some specific diagnostic markers. The current need to make the most of available economic and human resources has led to the production of diagnostic algorithms and guidelines designated for optimal strategic use of the tests and to increase the diagnostic appropriateness. An important role in this scenario was assumed by the laboratory autoimmunologist, whose task is not only to govern the analytical phase, but also to help clinicians in correctly choosing the most suitable test for each clinical situation and provide consultancy support. In this review, we summarize recent advances in technology, describe the diagnostic strategies and highlight the current role of the laboratory autoimmunologist in the clinical governance of autoimmune diagnostics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25398640     DOI: 10.1007/s12026-014-8587-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  58 in total

Review 1.  The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin.

Authors:  Renato Tozzoli; Nicola Bizzaro
Journal:  Autoimmun Rev       Date:  2012-02-12       Impact factor: 9.754

Review 2.  External Quality Assessment: an effective tool for Clinical Governance in laboratory medicine.

Authors:  Laura Sciacovelli; Sandra Secchiero; Lorena Zardo; Martina Zaninotto; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

3.  A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases.

Authors:  Nicola Bizzaro; Gabriella Morozzi
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

4.  International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Nancy Agmon-Levin; Jan Damoiseaux; Cees Kallenberg; Ulrich Sack; Torsten Witte; Manfred Herold; Xavier Bossuyt; Lucille Musset; Ricard Cervera; Aresio Plaza-Lopez; Carlos Dias; Maria José Sousa; Antonella Radice; Catharina Eriksson; Olof Hultgren; Markku Viander; Munther Khamashta; Stephan Regenass; Luis Eduardo Coelho Andrade; Allan Wiik; Angela Tincani; Johan Rönnelid; Donald B Bloch; Marvin J Fritzler; Edward K L Chan; I Garcia-De La Torre; Konstantin N Konstantinov; Robert Lahita; Merlin Wilson; Olli Vainio; Nicole Fabien; Renato Alberto Sinico; Pierluigi Meroni; Yehuda Shoenfeld
Journal:  Ann Rheum Dis       Date:  2013-10-14       Impact factor: 19.103

5.  Ligand assays: from electrophoresis to miniaturized microarrays.

Authors:  R P Ekins
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

Review 6.  Correct laboratory approach to APS diagnosis and monitoring.

Authors:  V Pengo; A Banzato; G Denas; S Padayattil Jose; E Bison; A Hoxha; A Ruffatti
Journal:  Autoimmun Rev       Date:  2012-12-03       Impact factor: 9.754

7.  The old and new tests for celiac disease: which is the best test combination to diagnose celiac disease in pediatric patients?

Authors:  Ignazio Brusca; Antonio Carroccio; Elio Tonutti; Danilo Villalta; Renato Tozzoli; Maria Barrale; Filippo M Sarullo; Pasquale Mansueto; Stella Maria La Chiusa; Giuseppe Iacono; Nicola Bizzaro
Journal:  Clin Chem Lab Med       Date:  2011-09-26       Impact factor: 3.694

8.  IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.

Authors:  Danilo Villalta; Elio Tonutti; Christian Prause; Sibylle Koletzko; H Holm Uhlig; Pieter Vermeersch; Xavier Bossuyt; Martin Stern; Martin W Laass; Julia H Ellis; Paul J Ciclitira; Thomas Richter; Cornelia Daehnrich; Wolfgang Schlumberger; Thomas Mothes
Journal:  Clin Chem       Date:  2009-12-18       Impact factor: 8.327

9.  Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis.

Authors:  Umberto Volta; Alessandro Granito; Claudia Parisi; Angela Fabbri; Erica Fiorini; Maria Piscaglia; Francesco Tovoli; Valentina Grasso; Paolo Muratori; Georgios Pappas; Roberto De Giorgio
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

Review 10.  Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent.

Authors:  Marvin J Fritzler
Journal:  Auto Immun Highlights       Date:  2012-03-21
View more
  6 in total

Review 1.  Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review.

Authors:  Renato Tozzoli; Danilo Villalta; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

2.  Automation, consolidation, and integration in autoimmune diagnostics.

Authors:  Renato Tozzoli; Federica D'Aurizio; Danilo Villalta; Nicola Bizzaro
Journal:  Auto Immun Highlights       Date:  2015-07-03

3.  Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods.

Authors:  Federica D'Aurizio; Paolo Metus; Annalisa Polizzi Anselmo; Danilo Villalta; Anna Ferrari; Roberto Castello; Graziella Giani; Elio Tonutti; Nicola Bizzaro; Renato Tozzoli
Journal:  Auto Immun Highlights       Date:  2015-08-15

4.  Antibody-controlled actuation of DNA-based molecular circuits.

Authors:  Wouter Engelen; Lenny H H Meijer; Bram Somers; Tom F A de Greef; Maarten Merkx
Journal:  Nat Commun       Date:  2017-02-17       Impact factor: 14.919

5.  Optimization of Laboratory Diagnostics of Primary Biliary Cholangitis: When Solid-Phase Assays and Immunofluorescence Combine.

Authors:  Federica Gaiani; Roberta Minerba; Alessandra Picanza; Annalisa Russo; Alessandra Melegari; Elena De Santis; Tommaso Trenti; Lucia Belloni; Silvia Peveri; Rosalia Aloe; Carlo Ferrari; Luigi Laghi; Gian Luigi de'Angelis; Chiara Bonaguri
Journal:  J Clin Med       Date:  2022-09-05       Impact factor: 4.964

Review 6.  Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Authors:  Mandy Sowa; Rico Hiemann; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.